Duclos-Vallée J C, Hadengue A, Ganne-Carrié N, Robin E, Degott C, Erlinger S
Service d'Hépatologie, Hôpital Beaujon, Clichy, France.
Dig Dis Sci. 1995 May;40(5):1069-73. doi: 10.1007/BF02064201.
We report a case of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome treated with cyclosporine A. Features of primary biliary cirrhosis were pruritus, high titer of antimitochondrial antibodies, inflammatory infiltrates surrounding interlobular bile ducts, and periportal granuloma. Features suggestive of autoimmune hepatitis were high titer of antinuclear antibodies, very high total immunoglobulins, and piecemeal necrosis. Because corticosteroids and ursodeoxycholic acid were inefficient, cyclosporine A was started at a dose of 3 mg/kg/day. A dramatic improvement in clinical condition, liver tests, and histology was noted. Discontinuation of cyclosporine A was followed by a clinical and histological relapse. Cyclosporine A reintroduction was again associated with a significant improvement. This case report suggests that in corticoresistant cases cyclosporine A could be an effective therapy for primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
我们报告一例用环孢素A治疗的原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征病例。原发性胆汁性肝硬化的特征为瘙痒、抗线粒体抗体高滴度、小叶间胆管周围炎性浸润及门周肉芽肿。提示自身免疫性肝炎的特征为抗核抗体高滴度、总免疫球蛋白极高及桥接坏死。由于皮质类固醇和熊去氧胆酸治疗无效,遂开始使用环孢素A,剂量为3mg/kg/天。临床状况、肝功能检查及组织学均有显著改善。停用环孢素A后出现临床及组织学复发。再次使用环孢素A后又有明显改善。本病例报告提示,在皮质类固醇抵抗的病例中,环孢素A可能是原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征的有效治疗方法。